Akebia Therapeutics, Inc. (AKBA)

Akebia Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 29, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	360	234	106	395	405	752
Market Cap Growth	25.67%	120.08%	-73.16%	-2.30%	-46.16%	16.23%
Enterprise Value	425	301	121	363	241	640
Last Close Price	1.71	1.24	0.58	2.26	2.80	6.32
PE Ratio	-	-4.43	-1.11	-1.33	-1.01	-2.68
PS Ratio	1.94	1.20	0.36	1.87	1.37	2.24
PB Ratio	-6.33	-7.64	20.30	5.34	1.63	1.90
P/FCF Ratio	-5.48	-9.99	-1.45	-1.56	-3.66	-2.85
P/OCF Ratio	-5.49	-9.99	-1.45	-1.56	-3.67	-2.92
EV/Sales Ratio	2.43	1.55	0.41	1.71	0.82	1.91
EV/EBITDA Ratio	104.07	-43.80	39.44	-1.91	-1.72	-2.66
EV/EBIT Ratio	-8.06	-6.76	-3.48	-1.59	-1.38	-2.29
EV/FCF Ratio	-6.93	-12.87	-1.64	-1.43	-2.18	-2.42
Debt / Equity Ratio	-3.10	-3.41	30.07	2.56	0.51	0.27
Debt / EBITDA Ratio	10.38	-	18.82	-	-	-
Debt / FCF Ratio	-2.68	-4.46	-2.15	-0.75	-1.14	-0.41
Asset Turnover	0.74	0.65	0.66	0.36	0.42	0.38
Inventory Turnover	1.38	2.13	0.77	1.67	0.72	0.91
Quick Ratio	0.65	0.82	1.01	0.79	1.59	0.90
Current Ratio	1.04	1.18	1.43	1.04	1.98	1.49
Return on Equity (ROE)	-	-	-237.83%	-175.37%	-119.82%	-54.27%
Return on Assets (ROA)	-8.84%	-9.30%	-4.89%	-24.27%	-15.41%	-19.74%
Return on Capital (ROIC)	-26.29%	-23.56%	-10.17%	-44.71%	-24.88%	-30.24%
Earnings Yield	-11.25%	-22.23%	-88.77%	-71.32%	-95.09%	-37.20%
FCF Yield	-10.85%	-10.01%	-69.03%	-63.99%	-27.35%	-35.13%
Buyback Yield / Dilution	-7.22%	-2.56%	-10.14%	-19.85%	-16.95%	-104.00%
Total Shareholder Return	-7.22%	-2.56%	-10.14%	-19.85%	-16.95%	-104.00%

Source: S&P Capital IQ. Standard template. Financial Sources.